drugset / Trial / NCT06199505
A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in China. The aim of the trial is to compare the efficacy and safety of GZR101 and insulin degludec/insulin aspart in insulin naïve or insulin treated subjects with type 2 diabetes.
Timeline
- Start
- 2023-11-21
- Primary completion
- 2024-06-28
- Completion
- 2024-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR101 | Unknown | — | Subcutaneous |
| Comparator | insulin degludec/insulin aspart | Unknown | — | Subcutaneous |